Showing results (121-130 of 202) with videos related to
Sort By:
Pageof 21
AIDS (London, England)|April 13, 2004
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up studyCharles Hicks, Martin S King, Roy M Gulick, et al.Lancet (London, England)|July 6, 2004
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classesBruno Ledergerber, Jens D Lundgren, A Sarah Walker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2009
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal, Amanda Mocroft, Jonathan A C Sterne, et al.Journal of Biomolecular Structure & Dynamics|March 18, 2021
Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infectionDennis C Copertino, Bruno C Casado Lima, Rodrigo R R Duarte, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2011
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivityTimothy J Wilkin, Mathew Bidwell Goetz, Robert Leduc, et al.Journal of Virology|May 23, 2008
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subjectAthe M N Tsibris, Manish Sagar, Roy M Gulick, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2014
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDSAdriana Weinberg, Ronald Bosch, Kara Bennett, et al.Annals of Internal Medicine|July 1, 2014
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial dataKatie R Mollan, Marlene Smurzynski, Joseph J Eron, et al.Pharmacogenetics and Genomics|December 3, 2014
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocolsDavid S Lehmann, Heather J Ribaudo, Eric S Daar, et al.Plos Genetics|April 26, 2021
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adultsBinglan Li, Yogasudha Veturi, Anurag Verma, et al.Pageof 21